{
    "2021-05-06": [
        [
            {
                "time": "2021-05-05",
                "original_text": "Let drugmakers keep their Covid vaccine profits",
                "features": {
                    "keywords": [
                        "drugmakers",
                        "Covid",
                        "vaccine",
                        "profits"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-05-06",
                "original_text": "India's COVID-19 cases soar with over 412,000 confirmed",
                "features": {
                    "keywords": [
                        "India",
                        "COVID-19",
                        "cases",
                        "soar"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-07",
                "original_text": "U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor",
                "features": {
                    "keywords": [
                        "U.S.",
                        "waiver",
                        "patent",
                        "protection",
                        "vaccines"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-08",
                "original_text": "This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "dividend",
                        "stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "The Biggest Loser With Johnson & Johnson's COVID Vaccine Manufacturing Woes",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "COVID",
                        "vaccine",
                        "manufacturing",
                        "woes"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "Is It Too Late to Buy Johnson & Johnson Stock?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "stock"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-11",
                "original_text": "Vaccine IP Waiver, Jobless Claims, Central Banks - What's Moving Markets",
                "features": {
                    "keywords": [
                        "vaccine",
                        "IP",
                        "waiver",
                        "jobless",
                        "claims",
                        "central",
                        "banks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "economy",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-12",
                "original_text": "Biden Administration Supports Patent Waivers for Coronavirus Vaccine",
                "features": {
                    "keywords": [
                        "Biden",
                        "administration",
                        "supports",
                        "patent",
                        "waivers",
                        "coronavirus",
                        "vaccine"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}